Non-Clinical Development Strategy

We develop a fail-proof strategy updated with recent advances for you that entails:

→Vigilantly selecting the most appropriate studies in relevant species.

→Mitigating significant risks by prioritizing the studies.

→Identifying grouping of studies based on the requirement of GLP / nonGLP status.

→Selecting the most appropriate time to initiate your study to ensure unparalleled results in economical pricing.

We provide customized services including:

→Fully integrated pre-clinical developmental support.

→Specific guidance to design pre-clinical toxicology for required components of product development.

These strategies will help you get your product regulated without any interruptions.